FDG–PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology

This publication has 17 references indexed in Scilit:

• Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• Positron Emission Tomography in the Pretreatment Evaluation and Follow-Up of Non-Small Cell Lung Cancer Patients Treated with Radiotherapy: Preliminary Findings
  American Journal of Clinical Oncology, 1996
• Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIa (N2) non-small-cell lung cancer
  The Journal of Thoracic and Cardiovascular Surgery, 1996
• Staging non—small cell lung cancer by whole-body positron emission tomographic imaging
  The Annals of Thoracic Surgery, 1995
• Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
  Journal of Clinical Oncology, 1995
• Neoadjuvant therapy: A novel and effective treatment for stage IIIb non-small cell lung cancer
  The Annals of Thoracic Surgery, 1994
• A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1994
• Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
  Radiology, 1993
• Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
  Journal of Clinical Oncology, 1992
• CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.
  Radiology, 1991